Title:
ブルトン型チロシンキナーゼ（Ｂｔｋ）阻害剤の使用
Document Type and Number:
Japanese Patent JP7366084
Kind Code:
B2
Abstract:
Methods are provided for treating a hematologic cancer comprising administering an anticancer agent to a subject identified as having an increased mobilization of a subpopulation of lymphocytes from a malignancy following administration of an irreversible Btk inhibitor. Methods also are provided for identification of subjects for treatment and the analysis of cells mobilized from a hematologic malignancy following administration of an irreversible Btk inhibitor.
More Like This:
| JP2807577 | [Title of Invention] Cyclic amide derivative |
| WO/2011/025947 | RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF |
| WO/2015/001489 | PHARMACEUTICAL COMPOSITIONS OF TICAGRELOR |
Inventors:
Buggy, Joseph Jay.
Elias, Lawrence
Fife, Gwen
Eric, Hedrick
Laurie, David Jay.
Modi, Tarak Dee.
Elias, Lawrence
Fife, Gwen
Eric, Hedrick
Laurie, David Jay.
Modi, Tarak Dee.
Application Number:
JP2021110943A
Publication Date:
October 20, 2023
Filing Date:
July 02, 2021
Export Citation:
Assignee:
Pharma Cyclics LLC
International Classes:
A61K31/519; A61K39/395; A61P35/00; A61P35/02; A61P43/00
Foreign References:
| US20110184001 |
Other References:
Ann.Oncol.,日本,2011年06月,Vol.22,iv135
Attorney, Agent or Firm:
Yoshihiro Kiyohara